Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)

✍ Scribed by Vulsteke, C.; Lambrechts, D.; Dieudonne, A.; Hatse, S.; Brouwers, B.; van Brussel, T.; Neven, P.; Belmans, A.; Schoffski, P.; Paridaens, R.; Wildiers, H.

• Book ID: 121835066
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 161 KB
• Volume: 24
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdt008